Ignite Creation Date:
2024-05-05 @ 4:58 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00354315
Status:
COMPLETED
Last Update Posted:
2009-02-16
First Post:
2006-07-18
Brief Title:
DÉCISION a Continuous Professional Development Program to Improve Optimal Drug Prescription a Feasibility Study
Sponsor:
CHU de Quebec-Universite Laval
Organization:
CHU de Quebec-Universite Laval
Study Overview
Official Title:
DÉCISION a Continuous Professional Development Program to Improve Optimal Drug Prescription a Feasibility Study
Status:
COMPLETED
Status Verified Date:
2008-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this project is to evaluate the feasibility of a larger randomized trial of the efficacy of DECISION a continuous professional development program integrating multiple components to promote shared decision making concerning drug prescription
Detailed Description:
The Conseil du médicament du Québec defines optimal drug use as a use that maximizes benefits and minimizes risks to population health by taking into account available options costs and resources as well as patient values and social values This definition appropriately recognizes the uncertainty surrounding the use of most drugs ie there is often more than one good therapeutic option The Ottawa Decision Support Framework ODSF guides practitioners in assessing decision-making needs in clinical practice providing support for client decision making and evaluating the effectiveness of their interventions DECISION is an innovative continuous professional development program for physicians based on the principles of ODSF and Evidence-Based Medicine It integrates multiple educational - behavioral change components that aim at promoting optimal shared decision making with respect to drug prescription The investigators hypothesize that optimal shared decision making should result in optimized prescription behaviors by the physician and optimized drug use by the patient The objective of this pilot clinical randomized trial of DECISION is to evaluate the feasibility of a larger randomized clinical trial in order to determine the efficacy of the program to promote optimal shared decision making in regards to drug prescription by physicians This pilot evaluation of the program will focus on one clinical theme antibiotic prescription for acute respiratory infections ARI
The program targets general practitioners and combines three strategies that were proven effective to improve healthcare practices
1 Interactive workshops
2 Reminders of expected behaviors
3 Feedbacks
Three 180-minute workshops will be held over a six-month period and will include
1 Retrieval and critical appraisal of information
2 Clinical practice guidelines
3 Acquisition of diagnostic skills
4 Communication of risks and benefits
5 Shared decision making skills
6 Barriers and facilitating factors to optimal shared decision making with respect to drug prescription
Family physicians from four large group practices -the randomization unit- in the province of Québec Canada will be randomly selected and assigned to one of the following interventions
1 Immediate DECISION antibioticsARI program
2 6-month delayed DECISION antibioticsARI program
The main outcome measure of this pilot trial is to determine the feasibility of implementing the DECISION program on a large scale Feasibility will be based on the proportion of contacted group practices that agree to participate the proportion of recruited physicians that participate in the workshops the level of satisfaction about the workshop and the proportion of missing data in each survey Secondary outcomes will include measure of decision to use antibiotics decisional conflict decisional regret prescription profile of antibiotics in ARI script concordance test physician reaction to uncertainty and intention to engage in SDM and to use clinical practice guidelines regarding the use of antibiotics in ARI in future clinical encounters
The investigators hypothesize that shared decision making will translate into an optimized prescription by the physician and will lead to an optimized drug use by the patient We believe that this project will help to enhance the health of the Quebec citizen by a better drug use by the patient
The program targets general practitioners and combines three strategies that were proven effective to improve healthcare practices
1 Interactive workshops
2 Reminders of expected behaviors
3 Feedbacks
Three 180-minute workshops will be held over a six-month period and will include
1 Retrieval and critical appraisal of information
2 Clinical practice guidelines
3 Acquisition of diagnostic skills
4 Communication of risks and benefits
5 Shared decision making skills
6 Barriers and facilitating factors to optimal shared decision making with respect to drug prescription
Family physicians from four large group practices -the randomization unit- in the province of Québec Canada will be randomly selected and assigned to one of the following interventions
1 Immediate DECISION antibioticsARI program
2 6-month delayed DECISION antibioticsARI program
The main outcome measure of this pilot trial is to determine the feasibility of implementing the DECISION program on a large scale Feasibility will be based on the proportion of contacted group practices that agree to participate the proportion of recruited physicians that participate in the workshops the level of satisfaction about the workshop and the proportion of missing data in each survey Secondary outcomes will include measure of decision to use antibiotics decisional conflict decisional regret prescription profile of antibiotics in ARI script concordance test physician reaction to uncertainty and intention to engage in SDM and to use clinical practice guidelines regarding the use of antibiotics in ARI in future clinical encounters
The investigators hypothesize that shared decision making will translate into an optimized prescription by the physician and will lead to an optimized drug use by the patient We believe that this project will help to enhance the health of the Quebec citizen by a better drug use by the patient
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| FRSQ-051711 | None | None | None |